Catalyst Pharmaceuticals, Inc.
CPRXNASDAQHealthcare● Active
$31.28
+$0.01(+0.03%)
Market Cap$3.8B
P/E Ratio—
52W High$32.56
52W Low$19.05
Catalyst Pharmaceuticals, Inc. (CPRX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CPRX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.71B | $0.52B | $0.14B | $0.30B | $0.19B |
| Net Receivables | $0.13B | $0.07B | $0.05B | $0.01B | $0.01B |
| Inventory | $0.04B | $0.02B | $0.02B | $0.01B | $0.01B |
| Total Current Assets | $0.89B | $0.62B | $0.22B | $0.32B | $0.21B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.13B | $0.16B | $0.19B | $0.03B | $0.00B |
| Total Assets | $1.11B | $0.85B | $0.47B | $0.38B | $0.24B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.02B | $0.01B | $0.00B | $0.00B |
| Total Current Liabilities | $0.15B | $0.12B | $0.08B | $0.06B | $0.03B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.15B | $0.12B | $0.08B | $0.08B | $0.03B |
| Stockholders Equity | |||||
| Retained Earnings | $0.47B | $0.29B | $0.12B | $0.05B | ($0.03B) |
| Total Stockholders Equity | $0.95B | $0.73B | $0.39B | $0.30B | $0.21B |
| Total Liab & Equity(computed) | $1.11B | $0.85B | $0.47B | $0.38B | $0.24B |
| Debt Summary | |||||
| Total Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Debt | ($0.71B) | ($0.51B) | ($0.13B) | ($0.29B) | ($0.17B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Catalyst Pharmaceuticals, Inc. data
About Catalyst Pharmaceuticals, Inc. (CPRX) Balance Sheet
Catalyst Pharmaceuticals, Inc. (CPRX) balance sheet shows total assets of $1.11B with cash of $0.71B. Total liabilities are $0.15B, total debt $0.00B, and stockholders equity $0.95B.
Frequently asked questions
CPRX · 4 questionsCatalyst Pharmaceuticals, Inc. has total debt of $0.00B with net debt of ($0.71B).
CPRX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10